The Equitable Implementation of Cystic Fibrosis Personalized Medicines in Canada

The Equitable Implementation of Cystic Fibrosis Personalized Medicines in Canada

This article identifies the potential sources of inequity in three stages of integrating cystic fibrosis personalized medicines into the Canadian healthcare system and proposes mitigating strategies: (1) clinical research and diagnostic testing; (2) regulatory oversight and market authorization; and...

Full description

Bibliographic Details
Main Authors: Genevieve Shemie, Minh Thu Nguyen, John Wallenburg, Felix Ratjen, Bartha Maria Knoppers
Format: Article
Language:English
Published: MDPI AG 2021-05-01
Series:Journal of Personalized Medicine
Subjects:
personalized medicines
cystic fibrosis
healthcare equity
access
health policy
ethics
Online Access:https://www.mdpi.com/2075-4426/11/5/382

Internet

https://www.mdpi.com/2075-4426/11/5/382

Similar Items